Amlodipine and Thrombocytosis - a phase IV clinical study of FDA data
Summary:
Thrombocytosis is found among people who take Amlodipine, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Amlodipine and have Thrombocytosis. It is created by eHealthMe based on reports of 285,218 people who have side effects when taking Amlodipine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
285,218 people reported to have side effects when taking Amlodipine.
Among them, 139 people (0.05%) have Thrombocytosis.
What is Amlodipine?
Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 292,106 Amlodipine users for its effectiveness, alternative drugs and more.
What is Thrombocytosis?
Thrombocytosis is found to be associated with 1,101 drugs and 728 conditions by eHealthMe.
Number of Amlodipine and Thrombocytosis reports submitted per year:

Time on Amlodipine when people have Thrombocytosis *:
Gender of people who have Thrombocytosis when taking Amlodipine*:
Age of people who have Thrombocytosis when taking Amlodipine *:
Common drugs people take besides Amlodipine *:
Common side effects people have besides Thrombocytosis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Amlodipine and have Thrombocytosis?
Check whether Thrombocytosis is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Thrombocytosis and when was it recovered:
Expand to all the drugs that have ingredients of amlodipine besylate:
Alternative drugs to, pros and cons of Amlodipine:
- Amlodipine (292,106 reports)
Common Amlodipine side effects:
- Fatigue (feeling of tiredness): 19,532 reports
- High blood pressure: 16,687 reports
- Diarrhea: 16,563 reports
- Breathing difficulty: 15,677 reports
- Dizziness: 13,385 reports
Browse all side effects of Amlodipine:
a b c d e f g h i j k l m n o p q r s t u v w x y zThrombocytosis treatments and more:
- Thrombocytosis (4,835 reports)
COVID vaccines that are related to Thrombocytosis:
- Thrombocytosis in Moderna COVID Vaccine
- Thrombocytosis in Pfizer BioNTech Covid Vaccine
- Thrombocytosis in Johnson and Johnson Covid Vaccine
Common drugs associated with Thrombocytosis:
- Nplate: 418 reports
- Aspirin: 324 reports
- Prednisone: 303 reports
- Methotrexate: 205 reports
- Pantoprazole: 150 reports
- Furosemide: 148 reports
- Amlodipine: 139 reports
- Metformin: 136 reports
- Jakafi: 134 reports
- Diazepam: 134 reports
All the drugs that are associated with Thrombocytosis:
- Thrombocytosis (1,101 drugs)
Common conditions associated with Thrombocytosis:
- High blood pressure: 267 reports
- Idiopathic thrombocytopenic purpura (itp): 245 reports
- Rheumatoid arthritis: 165 reports
- Osteoporosis: 139 reports
- Pain: 136 reports
All the conditions that are associated with Thrombocytosis:
- Thrombocytosis (728 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Amlodipine) and Amlodipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pataday and Arthropathy - 4 seconds ago
- Nicotine Polacrilex and Copegus drug interaction - 7 seconds ago
- Pruritus Aggravated and Gamma-Glutamyltransferase Increased - 9 seconds ago
- Ibuprofen and Tolsura drug interaction - 9 seconds ago
- Orphenadrine Citrate and Naprelan drug interaction - 11 seconds ago
- Prilosec Otc and Tibia Fracture - 14 seconds ago
- Methamphetamine Hydrochloride and Gabapentin drug interaction - 16 seconds ago
- Effexor Xr and Type 1 Diabetes - 18 seconds ago
- Enoxaparin Sodium and Gingivitis Aggravated - 27 seconds ago
- Videx and Pneumococcal Sepsis - 33 seconds ago